title: High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable.
authors.forename: Norbert
authors.initials: N
authors.lastname: Gattermann
authors.forename: Johan
authors.initials: J
authors.lastname: Billiet
authors.forename: Ralf
authors.initials: R
authors.lastname: Kronenwett
authors.forename: Esther
authors.initials: E
authors.lastname: Zipperer
authors.forename: Ulrich
authors.initials: U
authors.lastname: Germing
authors.forename: Friedel
authors.initials: F
authors.lastname: Nollet
authors.forename: Arnold
authors.initials: A
authors.lastname: Criel
authors.forename: Dominik
authors.initials: D
authors.lastname: Selleslag
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000756:Anemia, Sideroblastic / Q000235:genetics; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense; D009190:Myelodysplastic Syndromes / Q000175:diagnosis; D009196:Myeloproliferative Disorders / Q000175:diagnosis; D010976:Platelet Count; D013922:Thrombocytosis / Q000453:epidemiology / Q000235:genetics*
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2